Cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphoproliferative
neoplasms that exhibit a wide spectrum of immune-phenotypical, clinical, and …

Cutaneous T-cell lymphoma (CTCL) comprises a group of lymphoproliferative diseases
characterized by the accumulation of malignant T cells in chronically inflamed skin lesions …

The immune function of normal T cells partially depends on the maneuvering of lipid
metabolism through various stages and subsets. Interestingly, T-cell malignancies also …

Staphylococcus aureus and its toxins have been linked to disease progression and mortality
in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role …

Mycosis fungoides (MF) and Sézary syndrome (SS) are representative cutaneous
lymphomas. In their early stage, a small number of tumor cells and a large number of non …

Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma (CTCL) and
is characterized by epidermotrophism of malignant CD4+ T-lymphocytes. When MF …

ABSTRACT CTCL follows different courses depending on the clinical stage at the time of
diagnosis. Patients with early stage Mycosis Fungoides (MF) variant of CTCL may …

Microenvironment has a significant impact on the pathogenesis of cutaneous T-cell
lymphoma (CTCL), especially in the context of new emerging biologic therapies. Our aim …

Simple Summary Cutaneous T cell lymphomas (CTCLs) are a group of rare
lymphoproliferative malignancies manifesting in the skin. Cutaneous T cell lymphomas are …

Background Systemic chemotherapy is often the last resort of advanced cutaneous T‐cell
lymphoma (CTCL). Tumor recurrence and adverse effects of systemic chemotherapy are the …